Elevated serum IL-17 A and CCL20 levels as potential biomarkers in major psychotic disorders: a case-control study
The current study revealed that the serum levels of IL-17 A and CCL20 in schizophrenia patients are higher than those in the control group. Metabolic factors such as FBS, cholesterol, HDL, and LDL also showed significant differences between MPD and HC. In conclusion, the findings suggest that these two inflammatory factors could serve as potential therapeutic targets and prognostic biomarkers for schizophrenia.
Authors
- Somayeh Ghorbani (ORCID: https://orcid.org/0000-0002-5960-869X)
- Zanireh Salimi (ORCID: https://orcid.org/0000-0003-3973-4741)
- Parisa Ghasemi Noghabi
- Najmeh Shahini (ORCID: https://orcid.org/0000-0001-7781-6014)
- Yasser Bagheri
- Firoozeh Derakhshanpour
Institutions
- Mashhad University of Medical Sciences (IR)
- Golestan University (IR)
- Gonabad University of Medical Sciences (IR)
- Golestan University of Medical Sciences (IR)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1186/s12888-024-06032-3
- Citations
- 10
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 2.40
Funders
- Golestan University of Medical Sciences